Tørring, N., Borre, M., Sørensen, K., Andersen, C. L., Wiuf, C. & Ørntoft, T. F. (2007).
Genome-Wide analysis of allelic imbalance in laser microdissected prostate cancer tissue using the Affymetrix 50K Mapping array identifies genomic patterns associated with metastasis and differentiation.
British Journal of Cancer,
96(3), 499-506.
https://doi.org/10.1038/sj.bjc.6603476
Sørensen, K. D., Wild, P. J., Mortezavi, A.
, Adolf, K., Tørring, N., Heebøll, S., Ulhøi, B. P., Ottosen, P., Sulser, T., Hermanns, T., Moch, H.
, Borre, M., Ørntoft, T. F. & Dyrskjøt, L. (2009).
Genetic and Epigenetic SLC18A2 Silencing in Prostate Cancer Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy.
Clinical Cancer Research,
15(4), 1400-1410.
https://doi.org/10.1158/1078-0432.CCR-08-2268
Andersen, L. D., Zieger, K., Real, F. X., Malats, N., Carrato, A., Hurst, C., Kotwal, S., Knowles, M., Malmstrom, P.-U., de la Torre, M., Wester, K., Allory, Y., Vordos, D., Caillault, A., Radvanyi, F.
, Hein, A.-M. K., Jensen, J. L., Jensen, K. M.-E., Marcussen, N. & Ørntoft, T. F. (2007).
Gene expression signatures predict outcome in non-muscle invasive bladder carcinoma - a multi-center validation study.
Clinical Cancer Research,
13(12), 3545-51.
https://doi.org/10.1158/1078-0432.CCR-06-2940
Jensen, J. B., Jensen, K. M.-E., Ulhøi, B. P., Ørntoft, T. F. & Andersen, L. D. (2009).
Gene expression signature for metastatic urothelial carcinoma of the urinary bladder. Poster session presented at EAU 24th Congress, Stockholm, Sweden.
Jensen, M. A., Marcussen, N.
, Jensen, K. M.-E., Andersen, T. T., Andersen, L. D. & Ørntoft, T. F. (2005).
Gene expression profiling of noninvasive primary urothelial tumours using microarray.
Br. J. Cancer,
93(10).
Celis, J. E.
, Kruhøffer, M., Gromova, I., Frederiksen, C., Østergaard, M., Thykjaer, T., Gromov, P., Yu, J., Palsdottir, H., Magnusson, N. & Ørntoft, T. F. (2000).
Gene expression profiling: monitoring transcription and transition products using DNA microarrays and proteomics.
FEBS Letters,
2389, 1-15.
Andersen, L. D., Kruhøffer, M., Andersen, T. T., Marcussen, N., Jensen, J. L., Jensen, K. M.-E. & Ørntoft, T. F. (2004).
Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.
Cancer Research,
64(11), 4044-4048.
Thomsen, A. H., Gaml-Sørensen, A., Brix, N., Ernst, A., Lunddorf, L. L. H., Strandberg-Larsen, K., Højgaard, A.
& Ramlau-Hansen, C. H. (2022).
Gender incongruence and timing of puberty: a population-based cohort study.
Fertility and Sterility,
118(5), 938-945.
https://doi.org/10.1016/j.fertnstert.2022.07.018
Lu, Y., Fog-Poulsen, K., Nørregaard, R., Djurhuus, J. C. & Olsen, L. H. (2021).
Gender-dependent bladder response to one-day bladder outlet obstruction.
Journal of Pediatric Urology,
17(2), 170.e1-170.e10.
https://doi.org/10.1016/j.jpurol.2020.12.026
Lildal, S. K., Hansen, E. S. S., Laustsen, C., Nørregaard, R., Bertelsen, L. B., Madsen, K.
, Rasmussen, C. W., Osther, P. J. S.
& Jung, H. (2023).
Gadolinium-enhanced MRI visualizing backflow at increasing intra-renal pressure in a porcine model.
PLoS One,
18(2), Article e0281676.
https://doi.org/10.1371/journal.pone.0281676
Kaufmann, E., Black, P. C., Catto, J. W. F., Djaladat, H., Ghodoussipour, S., Hamilton-Reeves, J. M.
, Jensen, B. T., Kassouf, W., Lauridsen, S. V., Lerner, S. P., Llorente, C., Loftus, K., Lucca, I., Martini, A., Preston, M. A., Psutka, S. P., Sfakianos, J. P., Shah, J., Wettstein, M. S. ... Committee, O. B. O. T. E. R. A. S. C. (2023).
Functional Follow-Up After Cystectomy and Urinary Diversion: A Narrative Review.
JU open plus,
1(11), Article e00071.
https://doi.org/10.1097/JU9.0000000000000071,
https://doi.org/10.1097/JU9.0000000000000071Haldrup, J., Strand, S. H., Cieza-Borrella, C., Jakobsson, M. E.
, Riedel, M., Norgaard, M., Hedensted, S., Dagnaes-Hansen, F., Ulhoi, B. P., Eeles, R.
, Borre, M., Olsen, J. V.
, Thomsen, M., Kote-Jarai, Z.
& Sorensen, K. D. (2021).
FRMD6 has tumor suppressor functions in prostate cancer.
Oncogene,
40(4), 763–776.
https://doi.org/10.1038/s41388-020-01548-w
Cai, T., Tamanini, I., Mattevi, D., Verze, P., Palmieri, A., Malossini, G., Mirone, V., Novelli, A., Tascini, C.
& Johansen, T. E. B. (2020).
Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study.
International Journal of Antimicrobial Agents,
56(1), Article 105935.
https://doi.org/10.1016/j.ijantimicag.2020.105935Bjerre, E. D., Brasso, K., Jørgensen, A. B., Petersen, T. H., Eriksen, A. R., Tolver, A., Christensen, J. F., Poulsen, M. H.
, Madsen, S. S., Østergren, P. B.
, Borre, M., Krustrup, P., Johansen, C., Rørth, M. & Midtgaard, J. (2019).
Football Compared with Usual Care in Men with Prostate Cancer (FC Prostate Community Trial): A Pragmatic Multicentre Randomized Controlled Trial.
Sports Medicine,
49(1), 145-158.
https://doi.org/10.1007/s40279-018-1031-0Agerbæk, M., Alsner, J., Marcussen, N., Lundbeck, F. & Maase, H. V. D. (2006).
Focal S100A4 protein expression is an independent predictor of development of metastatic disease in cystectomized bladder cancer patients.
European Urology,
50(4), 777-785.
https://doi.org/10.1016/j.eururo.2006.02.027
Schjørring, O.
, Kun, A., Flyvbjerg, A., Kirkeby, H. J., Jensen, J. B. & Simonsen, U. (2012).
Flow-Evoked Vasodilation Is Blunted in Penile Arteries from Zucker Diabetic Fatty Rats.
Journal of Sexual Medicine, 1789-1800.
https://doi.org/10.1111/j.1743-6109.2012.02743.xDoizi, S., Knoll, T., Scoffone, C. M., Breda, A.
, Brehmer, M., Liatsikos, E., Cornu, J.-N. & Traxer, O. (2014).
First clinical evaluation of a new innovative ureteral access sheath (Re-Trace™): a European study.
World Journal of Urology,
32(1), 143-7.
https://doi.org/10.1007/s00345-013-1094-3Dadaev, T., Saunders, E. J., Newcombe, P. J., Anokian, E., Leongamornlert, D. A., Brook, M. N., Cieza-Borrella, C., Mijuskovic, M., Wakerell, S., Olama, A. A. A., Schumacher, F. R., Berndt, S. I., Benlloch, S., Ahmed, M., Goh, C., Sheng, X.
, Zhang, Z., Muir, K., Govindasami, K. ... PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium (2018).
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
Nature Communications,
9(1), Article 2256.
https://doi.org/10.1038/s41467-018-04109-8James, N. D., Caty, A., Payne, H.
, Borre, M., Zonnenberg, B. A., Beuzeboc, P., McIntosh, S., Morris, T., Phung, D. & Dawson, N. A. (2010).
Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial.
B J U International (Print),
106(7), 966-73.
https://doi.org/10.1111/j.1464-410X.2010.09638.xStrandgaard, T., Nordentoft, I., Birkenkamp-Demtröder, K., Salminen, L., Prip, F., Rasmussen, J., Andreasen, T. G., Lindskrog, S. V., Christensen, E., Lamy, P., Knudsen, M., Steiniche, T., Jensen, J. B. & Dyrskjøt, L. (2024).
Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer.
European Urology,
85(1), 82-92.
https://doi.org/10.1016/j.eururo.2023.07.014
Beukers, W., van der Keur, K. A., Kandimalla, R., Vergouwe, Y., Steyerberg, E. W., Boormans, J. L.
, Jensen, JB., Lorente, J. A., Real, F. X., Segersten, U.
, Orntoft, T. F., Malats, N., Malmström, P.-U.
, Dyrskjot, L. & Zwarthoff, E. C. (2017).
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.
Journal of Urology,
197(6), 1410-1418.
https://doi.org/10.1016/j.juro.2016.12.096Milling, R. V., Seyer-Hansen, A. D.
, Graugaard-Jensen, C., Jensen, J. B. & Kingo, P. S. (2024).
Female Sexual Function After Radical Cystectomy: A Cross-sectional Study.
European Urology Open Science,
70, 142-147.
https://doi.org/10.1016/j.euros.2024.10.013
Jakobsen, J. K., Szumniak, J., Stilling, C.
, Fledelius, J. & Bouchelouche, K. (2022).
FDG PET/CT in a Patient With Syphilis Suspected of Having Penile Cancer.
Clinical Nuclear Medicine,
47(9), e621-e623.
https://doi.org/10.1097/RLU.0000000000004170
Keller, A. K., Jørgensen, T. M., Vittrup, D. M., Kjerkegaard, U. K.
, Jespersen, B., Krag, S. R. P.
, Bibby, B. M. & Stolle, L. B. (2013).
Fast Detection of Renal Ischemia in Transplanted Kidneys With Delayed Graft Function-An Experimental Study.
Transplantation,
95(2), 275-279.
https://doi.org/10.1097/TP.0b013e318276a1c8
Rasmussen, M. M., Rawashdeh, Y. F. H., Clemmensen, D.
, Tankisi, H., Fuglsang-Frederiksen, A., Krogh, K. & Christensen, P. (2014).
Failure of urological improvement following the artificial somato-sensory reflex arch (Xiao procedure). Abstract from The 53rd ISCoS Annual Scientific Meeting, Maastricht, Netherlands.
Pool, M. B. F., Rozenberg, K. M.
, Lohmann, S., Ottens, P. J.
, Eijken, M., Keller, A. K., Jespersen, B., Ploeg, R. J., Leuvenink, H. G. D. & Moers, C. (2024).
Ex-Vivo Kidney Perfusion With Hemoglobin-Based Oxygen Carriers, Red Blood Cells, or No Oxygen Carrier.
Journal of Surgical Research,
301, 248-258.
https://doi.org/10.1016/j.jss.2024.06.010Lohmann, S., Eijken, M., Møldrup, U., Møller, B. K., Hunter, J., Moers, C., Leuvenink, H., Ploeg, R. J., Clahsen-van Groningen, M. C., Hoogduijn, M., Baan, C. C.
, Keller, A. K. & Jespersen, B. (2021).
Ex Vivo Administration of Mesenchymal Stromal Cells in Kidney Grafts Against Ischemia-reperfusion Injury—Effective Delivery Without Kidney Function Improvement Posttransplant.
Transplantation,
105(3), 517-528.
https://doi.org/10.1097/TP.0000000000003429
Chen, L.-M., Chang, M., Dai, Y., Chai, K. X.
, Dyrskjøt, L., Sanchez-Cabayo, M., Szarvas, T., Zwarthoff, E. C., Lokeswhar, V., Jeronimo, C., Parker, A. S., Ross, S.
, Borre, M., Orntoft, T. F., Jaeger, T., Beukers, W., Lopez, L. E., Henrique, R., Young, P. R. ... Rosser, C. J. (2014).
External Validation of a Multiplex Urinary Protein Panel for the Detection of Bladder Cancer in a Multicenter Cohort.
Cancer Epidemiology, Biomarkers & Prevention.
https://doi.org/10.1158/1055-9965.EPI-14-0029Mortensen, M. M., Høyer, S., Lynnerup, A.-S., Ørntoft, T. F., Sørensen, K. D., Borre, M. & Dyrskjøt, L. (2015).
Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy.
Scientific Reports,
5, 16018.
https://doi.org/10.1038/srep16018
Bentzon, D. N., Borre, M., Ørntoft, T. F., Mortensen, M. M. & Andersen, L. D. (2012).
Expression Profiling of Hereditary versus Sporadic Prostate Cancer Suggests CYR61, EGR3, KLF6 and SNF1LK as Differentially Expressed Genes.
Open Journal of Urology, 45-54.
Thøgersen, V. B.
, Sørensen, B. S., Bross, P., Ørntoft, T., Wolf, H. & Nexø, E. (1999).
Expression of transforming growth factor alpha and epidermal growth factor receptor in human bladder cancer.
Scandinavian Journal of Clinical & Laboratory Investigation,
59(4), 267-277.
https://doi.org/10.1080/00365519950185634Laurberg, J. R., Brems-Eskildsen, A. S., Nordentoft, I., Fristrup, N., Schepeler, T., Ulhøi, B. P., Agerbaek, M., Hartmann, A., Bertz, S., Wittlinger, M., Fietkau, R., Rödel, C.
, Borre, M., Jensen, J. B., Orntoft, T. & Andersen, L. D. (2012).
Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.
B J U International (Online).
https://doi.org/10.1111/j.1464-410X.2012.11564.x
Fristrup, N., Andersen, L. D., Ørntoft, T. F., Ulhøi, B. P. & Borre, M. (2009).
Expression of Maspin, Survin and Cathespin E predict progression in non-muscle invasive bladder cancer. Poster session presented at NUF, Iceland.
